Omada Health carries a market capitalization of 1.33B, placing it among publicly traded companies globally. Its enterprise value stands at 1.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.33B |
| Enterprise Value | 1.11B |
Omada Health currently has 60.61M shares outstanding.
| Shares Outstanding | 60.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Omada Health trades at a trailing price-to-earnings ratio of 298.69. The price-to-sales ratio is 4.15, and the price-to-book ratio stands at 5.26.
| PE Ratio | 298.69 |
| PS Ratio | 4.15 |
| PB Ratio | 5.26 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | 54.43 |
| P/OCF Ratio | 54.29 |
On an enterprise value basis, Omada Health trades at an EV/EBITDA multiple of 204.12 and an EV/FCF ratio of 44.27.
| EV / Sales | 3.58 |
| EV / EBITDA | 204.12 |
| EV / EBIT | N/A |
| EV / FCF | 44.27 |
Omada Health maintains a current ratio of 3.91, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.91 |
| Quick Ratio | 3.69 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 13.65 |
Omada Health posts a return on equity of 1.84 and a return on invested capital of -0.19.
| Return on Equity (ROE) | 1.84 |
| Return on Assets (ROA) | 1.36 |
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Capital Employed (ROCE) | 1.89 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 25.97 |
Omada Health's stock has declined approximately -5.39049% over the past 52 weeks. The 50-day moving average sits at 22.52, while the 200-day moving average is 16.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.39049% |
| 50-Day Moving Average | 22.52 |
| 200-Day Moving Average | 16.96 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Omada Health generated 309.76M in revenue and converted that into 4.31M in net income, yielding earnings per share of 0.07. EBITDA reached 5.43M, while operating income came in at -464,000.00.
| Revenue | 309.76M |
| Gross Profit | 211.21M |
| Operating Income | -464,000.00 |
| Pretax Income | 4.31M |
| Net Income | 4.31M |
| EBITDA | 5.43M |
| EBIT | -464,000.00 |
| Earnings Per Share (EPS) | 0.07 |
Total book value stands at 252.74M, with working capital of 219.43M providing operational flexibility.
| Cash & Cash Equivalents | 221.71M |
| Total Debt | N/A |
| Net Debt | -221.71M |
| Equity (Book Value) | 252.74M |
| Book Value Per Share | 4.17 |
| Working Capital | 219.43M |
Omada Health produced 23.69M in operating cash flow over the past twelve months. After subtracting -960,000.00 in capital expenditures, free cash flow totaled 22.73M - equivalent to 0.39 per share.
| Operating Cash Flow | 23.69M |
| Capital Expenditures | -960,000.00 |
| Free Cash Flow | 22.73M |
| FCF Per Share | 0.39 |
Omada Health operates with a gross margin of 68.19, reflecting its pricing power and cost economics. The operating margin of -0.15 and net profit margin of 1.39 provide insight into operational efficiency.
| Gross Margin | 68.19 |
| Operating Margin | -0.15 |
| Pretax Margin | 1.39 |
| Profit Margin | 1.39 |
| EBITDA Margin | 1.75 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.40 |
| FCF Yield | 1.84 |
Omada Health posts an Altman Z-Score of 10.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.37 |